US Patent 8232371 Modified human interferon polypeptides and their uses

Patent 8232371 was granted and assigned to Ambrx on July, 2012 by the United States Patent and Trademark Office.

Is a

Current Assignee

Patent Jurisdiction

Patent Number

Date of Patent

July 31, 2012

Patent Application Number

13315219

Date Filed

December 8, 2011

Patent Citations Received

Patent Primary Examiner

Patent abstract

Modified interferon polypeptides with at least one non-naturally-encoded amino acid and uses thereof are provided.

No Timeline data yet.

Title

Author

Link

Type

Date

No Further Resources data yet.

Find more entities like US Patent 8232371 Modified human interferon polypeptides and their uses

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.